This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: University of Pennsylvania, Arsenal Biosciences, Inc., Google Inc.. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Francisco, CA (US) (2012)
- Philadelphia, PA (US) (2024)
Company Filing History:
2 out of 2,663 
1 out of 5 
1 out of 34,018 
Years Active: 2012-2026
Title: Omar Khan: Innovator in Immunology
Introduction
Omar Khan is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of immunology. With a total of two patents to his name, he has made strides in developing innovative solutions for treating diseases associated with exhausted T cells.
Latest Patents
Khan's latest patents include groundbreaking work on immune cells that have co-expressed shRNAs and logic gate systems. This invention provides recombinant nucleic acids encoding chimeric priming receptors that bind ALPG/P, chimeric antigen receptors that bind MSLN, and shRNA that target FAS, PTPN2, and/or TOX. Additionally, he has developed methods and compositions for treating diseases characterized by the presence of exhausted T cells, offering new avenues for detection and treatment.
Career Highlights
Throughout his career, Omar Khan has worked with esteemed institutions such as the University of Pennsylvania and Arsenal Biosciences, Inc. His work has been pivotal in advancing the understanding of T cell exhaustion and its implications for various diseases.
Collaborations
Khan has collaborated with notable professionals in his field, including E John Wherry and Bertram Bengsch. These partnerships have further enriched his research and contributed to the development of innovative therapeutic strategies.
Conclusion
Omar Khan's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treating diseases related to T cell exhaustion.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile